Skip to main content
Clinical Trials/JPRN-UMIN000033065
JPRN-UMIN000033065
Recruiting
未知

Analysis on individual difference in pharmacokinetics of tolvaptan and its metabolites, and investigation on predictive parameters of tolvaptan response and adverse effects in Japanese patiens - Analysis on individual difference in pharmacokinetics of tolvaptan and its metabolites, and investigation on predictive parameters of tolvaptan response and adverse effects in Japanese patiens

Department of Hospital pharmacy Hamamatsu University School of Medicine0 sites200 target enrollmentJune 21, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
heart failures, cirrhosis
Sponsor
Department of Hospital pharmacy Hamamatsu University School of Medicine
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2018
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Hospital pharmacy Hamamatsu University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients discontinuing tolvaptan 2\. Patients who are judged by physicians as inappropriate for study enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials